Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ott

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Thrombosis and Thrombolysis|March 20, 2017
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillationB Steppich, F Dobler, L C Brendel, et al.
Thrombosis and Haemostasis|February 10, 2012
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosisA Stein, F Mohr, M Laux, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 24, 2017
The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxabanL C Brendel, F Dobler, G Hessling, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2023
Stem Cell Therapy after Acute Myocardial Infarction-The Emperor's New Clothes?: Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients with Acute Myocardial Infarction: A Randomized Controlled Trial. JAMA 295: 1003-1010, 2006D Zohlnhofer, I Ott, J Mehilli, et al.
Biochimica Et Biophysica Acta|January 21, 2014
Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivoE Jortzik, M Farhadi, R Ahmadi, et al.
Metallomics : Integrated Biometal Science|February 6, 2018
The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogueD B Shpakovsky, A A Shtil, E V Kharitonashvili, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Thrombosis and Thrombolysis|March 20, 2017
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillationB Steppich, F Dobler, L C Brendel, et al.
Thrombosis and Haemostasis|February 10, 2012
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosisA Stein, F Mohr, M Laux, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 24, 2017
The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxabanL C Brendel, F Dobler, G Hessling, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2023
Stem Cell Therapy after Acute Myocardial Infarction-The Emperor's New Clothes?: Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients with Acute Myocardial Infarction: A Randomized Controlled Trial. JAMA 295: 1003-1010, 2006D Zohlnhofer, I Ott, J Mehilli, et al.
Biochimica Et Biophysica Acta|January 21, 2014
Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivoE Jortzik, M Farhadi, R Ahmadi, et al.
Metallomics : Integrated Biometal Science|February 6, 2018
The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogueD B Shpakovsky, A A Shtil, E V Kharitonashvili, et al.
Pageof 7